Henan Yonghe Pharmaceutical Co., Ltd.
-
Founded in:
1997-09-10 -
Country:
China -
Address:
No. 28, Yinping Road, Zhengzhou High-tech Development Zone -
Tax NO.:
91410100268054747H -
Registered Funds:
35 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CALCIUM GLUCONATE MONOHYDRATE |
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.
More
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc. |
0.5g | 66905-23-5 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Lysine hydrochloride |
The lysine hydrochloride contained in this product is one of the essential amino acids for the human body, especially for children in the developmental period, recovery period after illness, pregnancy and lactation period. Lack of it can cause developmental problems, lack of appetite, weight loss and hypoproteinemia.
More
The lysine hydrochloride contained in this product is one of the essential amino acids for the human body, especially for children in the developmental period, recovery period after illness, pregnancy and lactation period. Lack of it can cause developmental problems, lack of appetite, weight loss and hypoproteinemia. |
10098-89-2 | 16 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfamonomethoxine |
This product is a long-acting sulfonamide drug. It has antibacterial effects on non-enzyme-producing Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonella, Shigella and other Enterobacteriaceae, Neisseria gonorrhoeae, Neisseria meningitidis, and Haemophilus influenzae. Sulfonamide drugs are broad-spectrum antibacterial agents. Their mechanism of action is that they are similar in structure to para-aminobenzoic acid (PABA) and can compete with PABA for dihydrofolate synthase in bacteria, thereby preventing PABA from synthesizing folic acid required by bacteria as a raw material and reducing the amount of metabolically active tetrahydrofolate, which is an essential substance for bacteria to synthesize purines, thymine nucleotides and deoxyribonucleic acid (DNA), thereby inhibiting the growth and reproduction of bacteria.
More
This product is a long-acting sulfonamide drug. It has antibacterial effects on non-enzyme-producing Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonella, Shigella and other Enterobacteriaceae, Neisseria gonorrhoeae, Neisseria meningitidis, and Haemophilus influenzae. Sulfonamide drugs are broad-spectrum antibacterial agents. Their mechanism of action is that they are similar in structure to para-aminobenzoic acid (PABA) and can compete with PABA for dihydrofolate synthase in bacteria, thereby preventing PABA from synthesizing folic acid required by bacteria as a raw material and reducing the amount of metabolically active tetrahydrofolate, which is an essential substance for bacteria to synthesize purines, thymine nucleotides and deoxyribonucleic acid (DNA), thereby inhibiting the growth and reproduction of bacteria. |
1220-83-3 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gastrodin |
It can restore the imbalance between the excitation and inhibition of the cerebral cortex, and has central inhibition effects such as sedation, hypnosis and analgesia. It also increases cerebral blood flow and relieves cerebral vasospasm.
More
It can restore the imbalance between the excitation and inhibition of the cerebral cortex, and has central inhibition effects such as sedation, hypnosis and analgesia. It also increases cerebral blood flow and relieves cerebral vasospasm. |
50mg | 62499-27-8 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sparfloxacin |
This product is a quinolone antibacterial drug. It is a broad-spectrum antibacterial drug. It has obvious antibacterial effects on Gram-positive bacteria including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, and Enterococcus faecalis; it also has good antibacterial effects on Gram-negative bacteria Escherichia coli, Klebsiella, Salmonella, Shigella, Vibrio parahaemolyticus, Proteus, Enterobacter, Pseudomonas, Acinetobacter, Neisseria (Neisseria gonorrhoeae, etc.). This product also has good antibacterial effects on mycoplasma, chlamydia, Legionella, anaerobic bacteria including Bacteroides fragilis and Mycobacterium. The mechanism of action of this product is to inhibit the action of DNA gyrase in the process of bacterial DNA synthesis and play a bactericidal role.
More
This product is a quinolone antibacterial drug. It is a broad-spectrum antibacterial drug. It has obvious antibacterial effects on Gram-positive bacteria including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, and Enterococcus faecalis; it also has good antibacterial effects on Gram-negative bacteria Escherichia coli, Klebsiella, Salmonella, Shigella, Vibrio parahaemolyticus, Proteus, Enterobacter, Pseudomonas, Acinetobacter, Neisseria (Neisseria gonorrhoeae, etc.). This product also has good antibacterial effects on mycoplasma, chlamydia, Legionella, anaerobic bacteria including Bacteroides fragilis and Mycobacterium. The mechanism of action of this product is to inhibit the action of DNA gyrase in the process of bacterial DNA synthesis and play a bactericidal role. |
110871-86-8 | 6 |